Drug Approval | December 04, 2024
Gland Pharma receives approval for Latanoprost Opthalmic Solution, 0.005%
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
Spread over 1.26 lakh sq ft building, the super-specialty eye hospital will perform 30,000 free eye surgeries annually for economically weaker sections
Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The product is bioequivalent and therapeutically equivalent to the reference listed drug
_256_384.jpeg)
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Travoprost Ophthalmic Solution USP, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Acetazolamide is used to treat glaucoma
Subscribe To Our Newsletter & Stay Updated
